Hosam Hasan‐Ali

ORCID: 0000-0002-7248-0125
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myocardial Infarction Research
  • Cardiac Imaging and Diagnostics
  • Cardiac Valve Diseases and Treatments
  • Coronary Interventions and Diagnostics
  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Cardiac Arrhythmias and Treatments
  • Lipoproteins and Cardiovascular Health
  • Cardiac Structural Anomalies and Repair
  • Atrial Fibrillation Management and Outcomes
  • Cardiac electrophysiology and arrhythmias
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Vascular Procedures and Complications
  • Infective Endocarditis Diagnosis and Management
  • Cardiac Health and Mental Health
  • Venous Thromboembolism Diagnosis and Management
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cardiovascular and Diving-Related Complications
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Disease and Adiposity
  • Cardiovascular Health and Risk Factors
  • Health Promotion and Cardiovascular Prevention
  • Adipokines, Inflammation, and Metabolic Diseases
  • Diabetes Treatment and Management
  • Long-Term Effects of COVID-19

Assiut University
2014-2025

Leeds Teaching Hospitals NHS Trust
2022

University of Leeds
2021-2022

European Society of Cardiology
2022

Assiut University Hospitals
2007-2021

Cairo University
2019

Hôpital Européen Georges-Pompidou
2019

Ospedale San Luigi Gonzaga
2018

GTx (United States)
2011

Leiden University Medical Center
2009

The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice.A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres 81 regions 27 countries.Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later.A total 8261 patients (females 26%) interviewed. Nineteen per cent smoked 55% them persistent smokers, 38% obese (body mass...

10.1177/2047487318825350 article EN European Journal of Preventive Cardiology 2019-02-10
Nikolaus Marx Massimo Federici Katharina Schütt Dirk Müller‐Wieland Ramzi Ajjan and 95 more Manuel J. Antunes Ruxandra Christodorescu Carolyn Crawford Emanuele Di Angelantonio Björn Eliasson Christine Espinola‐Klein Laurent Fauchier Martin Halle William G. Herrington Alexandra Kautzky‐Willer Ekaterini Lambrinou Maciej Lesiak Maddalena Lettino Darren K. McGuire Wilfried Müllens Bianca Rocca Naveed Sattar Eva Prescott Francesco Cosentino Magdy Abdelhamid Victor Aboyans Sotiris Antoniou Riccardo Asteggiano Iris Baumgärtner Sergio Buccheri Héctor Bueno Jelena Čelutkienė Alaide Chieffo Christina Christersson Andrew J.S. Coats Bernard Cosyns Martin Czerny Christi Deaton Volkmar Falk Brian A. Ference Gerasimos Filippatos Miles Fisher Heikki Huikuri Borja Ibáñez Tiny Jaarsma Stefan James Kamlesh Khunti Lars Køber Konstantinos C. Koskinas Basil S. Lewis Maja‐Lisa Løchen John W. McEvoy Borislava Mihaylova Richard Mindham Lis Neubeck Jens Cosedis Nielsen Gianfranco Parati Agnès Pasquet Carlo Patrono Steffen E. Petersen Massimo Piepoli Amina Rakisheva Xavier Rosselló Peter Rossing Lars Rydén Eberhard Standl Lâle Tokgözoğlu Rhian M. Touyz Frank L.J. Visseren Massimo Volpe Christiaan Vrints Adam Witkowski Lusine Hazarapetyan Andreas Zirlik Yasmin Rustamova Philippe van de Borne Dragan Lović Nina Gotcheva Davor Miličić Petros Agathangelou Michal Vráblík Morten Schou Hosam Hasan‐Ali Margus Viigimaa Riikka Lautamäki Victor Aboyans Zurab Klimiashvili Malte Kelm Gerasimos Siasos Róbert Gábor Kiss Berglind Libungan Maeve Durkan Barak Zafrir Furio Colivicchi Meiramgul Tundybayeva Ibadete Bytyçi Erkin М Мirrakhimov Kārlis Trušinskis Georges Saadé Jolita Badarienė

The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy, and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...

10.1093/eurheartj/ehad192 article EN cc-by-nc-nd European Heart Journal 2023-08-25
J Milosavljević L. Jovovic Roman Margoczy Gabriel Valočík Martin Studenčan and 95 more Francisco Calvo Irene Méndez Alyana Gomez P. L. Sánchez Fernandez G. M. Valenzuela M Cladellas D.V. Villegas Sergio Moral Irene Menduiña Gallego Rafael Payá Luis Caballero Richard R. Paton Esther Esteban Cristina Iglesia-Carreno M ALBERCA Alfonso Valle M. J. Molina-Mora N. Castro Nurten Sayar Abdullah Orhan Demirtaş Asuman Biçer Yeşilay S. Demir Atilla Bozkurt Batur Gönenç Kanar Naile Eriş Güdül Tarık Yıldırım Gökay Taylan Kadir Uğur Mert Mustafa Adem Yılmaztepe Gurbet Özge Mert Kahraman Coşansu M. R. Sayin Turgut Karabağ Eorp Vhd Ii Investigators Bernard Iung Victoria Delgado Raphael Rosenhek Susanna Price Bernard Prendergast Olaf Wendler Michele De Bonis Christophe Tribouilloy Arturo Evangelista Alexander Bogachev‐Prokophiev Astrid Apor Hueseyin Ince Cécile Laroche Luc Piérard Michael Haude Gerhard Hindricks Frank Ruschitzka Stefan Windecker Jeroen J. Bax Aldo P. Maggioni Alec Vahanian Souad Mekhaldi Katell Lemaitre Sébastien Authier H. Druais A Goda Julia Mascherbauer Fuad Samadov Kateřina Linhartová Nikolaj Ihlemann Magdy Abdelhamid Elizabeta Srbinovska Kostovska Gani Bajraktari Erkin М Мirrakhimov David Cassar Regina Ribeiras Branko Beleslin Iveta Šimková Sait Mesut Doğan Shelley Rahman-Haley E Shirka E Dado E Zëra Laura Bica Maria Heger Fargana Muslumova T. Jahangirov Tahir Ahmedov S. Husseynov Agnès Pasquet Bernard Cosyns Guy Van Camp S Sindelárová Marian Branny Ilona Pařenicová Dagmar Jungwirtova Vondrackova Miroslav Homza Jiří Ostřanský Hosam Hasan‐Ali Yasser Ahmed Abdelhady Mohamed Hassan

Background: Valvular heart disease (VHD) is an important cause of mortality and morbidity has been subject to changes in management. The VHD II survey was designed by the EURObservational Research Programme European Society Cardiology analyze actual management compare practice with guidelines. Methods: Patients severe native or previous valvular intervention were enrolled prospectively across 28 countries over a 3-month period 2017. Indications for considered concordant if performed...

10.1161/circulationaha.119.041080 article EN Circulation 2019-09-12

European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) V in primary care was carried out the Society of Cardiology EURObservational Research Programme 2016-2018. The main objective determine whether 2016 Joint Societies' guidelines cardiovascular disease prevention people at high risk have been implemented clinical practice.The method used a cross-sectional survey 78 centres from 16 countries. Patients without history atherosclerotic either started...

10.1177/2047487320908698 article EN cc-by European Journal of Preventive Cardiology 2020-03-20

INTERASPIRE is an international study of coronary heart disease (CHD) patients, designed to measure if guideline standards for secondary prevention and cardiac rehabilitation are being achieved in a timely manner. Between 2020 2023, adults hospitalized the preceding 6-24 months with incident or recurrent CHD were sampled 14 countries from all 6 World Health Organization regions invited standardized interview examination. Direct age sex standardization was used country-level prevalence...

10.1093/eurheartj/ehae558 article EN other-oa European Heart Journal 2024-08-30

The association of adipocyte-derived proteins, adiponectin and leptin, with the degree coronary atherosclerosis has not been well elucidated. This study aimed to determine relationship between serum leptin presence atherosclerosis.Seventy patients 20 matched controls were recruited. Angiographic evaluation was carried out by assessing three atherosclerotic indices, severity (transverse disease), extent (longitudinal pattern (lesion complexity).The independent predictors larger waist/hip...

10.1097/mca.0b013e3283452431 article EN Coronary Artery Disease 2011-03-05
Fotios Barkas Julia Brandts Dirk De Bacquer Catriona Jennings Guy De Backer and 95 more Kornelia Kotseva Lars Rydén Gregory Y. H. Lip Raúl D. Santos Peter Libby Iris Erlund Sandra Ganly Terhi Vihervaara Agnieszka Adamska Ana Abreu Wael Almahmeed Ade Meidian Ambari Junbo Ge Hosam Hasan‐Ali Yong Huo Piotr Jankowski Rodney M Jimenez Yong Li Ahmad Syadi Mahmood Zuhdi Abel Makubi Amam Mbakwem Lilian Mbau José L. Estrada Okechukwu S. Ogah Elijah Ogola Adalberto Quintero–Baiz Mahmoud U. Sani María Inés Sosa Liprandi Jack Wei Chieh Tan Miguel Urina‐Triana Tee Joo Yeo D. Wood John W. McEvoy Kausik K. Ray John W. McEvoy Dora Wood Agnieszka Adamska Guy De Backer Dirk De Bacquer Iris Erlund Sandra Ganly Catriona Jennings Kornelia Kotseva Gregory Y.H. Lip Kausik K. Ray Lars Rydén Ana Abreu Wael Almahmeed Ade Meidian Ambari Junbo Ge Hosam Hasan‐Ali Yong Huo P. Jankowski R. Jiménez Yonghong Li A.S. Mahmood Zuhdi Abel Makubi Amam Mbakwem Lilian Mbau José L. Estrada Okechukwu S. Ogah Elijah Ogola Adalberto Quintero-Baiz Mahmoud U. Sani María Inés Sosa Liprandi Jack W. Tan Miguel Urina‐Triana Tee Joo Yeo David A. Wood Agnieszka Adamska Catriona Jennings Kornelia Kotseva Sandra Ganly A. Zekic Lars Rydén Darrell Salako C Toulouse Gaurav Chhabra Roger G. Spragg Michael Sullivan Dirk De Bacquer Iris Erlund Elina Järvensivu Terhi Vihervaara Héctor Deschle J. Estrada MI Sosa Liprandi S.R. Bellia R. Villarreal Melisa Elfman José Ramón Azanza Perea F. Lombardi Walter Massón Beatriz Castaño Antonio Iglesias Gamarra

10.1016/j.jacc.2025.04.010 article EN Journal of the American College of Cardiology 2025-05-26

Carvedilol is a novel β-adrenoreceptor blocker, with antioxidant properties inhibiting lipid peroxidation and preventing the depletion of endogenous antioxidants. Moreover, carvedilol was reported to enhance expression Bcl-2 gene, which has antiapoptotic effects. There are few researches testing protective effect on development diabetic cardiomyopathy nephropathy. In this study, we induced diabetes mellitus in male Wistar albino rats. We investigated carvedilol, as well vitamin E,...

10.1055/s-0034-1385855 article EN Hormone and Metabolic Research 2014-08-08

This study was performed to assess the incidence, patient characteristics and predictors of aborted myocardial infarction (MI) in patients with ST-segment elevation MI (STEMI) undergoing primary percutaneous coronary intervention (PPCI).We enrolled 179 consecutive STEMI within a fixed protocol for PPCI (Leiden MISSION! project); 90 received abciximab bolus hospital (in-hospital group) 89 ambulance (pre-hospital group). Thirty-two (18%) fulfilled criteria an MI. The incidence four times...

10.4244/eijv4i5a110 article EN EuroIntervention 2009-03-01

We investigated the incidence of radial anomalies (RA) in patients undergoing transradial (TR) coronary procedure and their impact on procedural outcome Egyptian population. Radial are considered an important factor for failure. Information about anatomical variation is limited our performed a multicentre prospective study Egypt. A total 650 consecutive first TR were recruited from January 2013 till 2015. By retrograde arteriography we assessed frequency RA outcome. studied, 74% male, mean...

10.1016/j.ehj.2015.07.001 article EN cc-by-nc-nd The Egyptian Heart Journal 2015-08-21

PTMC produces significant changes in mitral valve morphology as improvement leaflets mobility. The determinants of such have not been assessed before.The study included 291 symptomatic patients with stenosis undergoing PTMC. Post-PTMC subvalvular splitting area was a determinant post-PTMC excursion both the anterior (B 0.16, 95% CI 0.03 to 0.30, p < 0.05) and posterior 0.12, 0.01 0.24, leaflets. Another transmitral pressure gradient for -0.02, -0.04 -0.005, 0.01) -0.01, excursion....

10.1186/1476-7120-5-48 article EN cc-by Cardiovascular Ultrasound 2007-12-01

Optical coherence tomography (OCT) provides valuable information to guide percutaneous coronary intervention (PCI) in acute syndrome (ACS) regarding lesion preparation, stent sizing, and optimization. The aim of the present study was compare lumen expansion stent-treated lesions immediately after procedure for ACS between OCT-guided PCI angiography-guided PCI.

10.1253/circj.cj-20-0942 article EN Circulation Journal 2021-01-19

To evaluate outcomes of percutaneous left atrial appendage closure (LAAC) in patients with congestive heart failure (CHF) and non-valvular fibrillation (AF) a consecutive, industry-independent registry associated periprocedural success complications during long-term follow-up.For this analysis, we included who underwent transcatheter LAAC from January 2014 to December 2019 at the University Heart Center Lübeck, Germany, compared presence CHF defined as reduced ventricular ejection fraction...

10.1002/ehf2.13698 article EN ESC Heart Failure 2021-11-15

This prospective cross-sectional observational study aimed at reporting the demographics of ACS patients admitted to Assiut University Hospital, Egypt, and validating both TIMI (Thrombolysis in Myocardial Infarction) GRACE (Global Registry Acute Coronary Events) scores prediction in-hospital MACE 30-day mortality recurrent MI ST-elevation myocardial infarction (STEMI) unstable angina/non-ST-elevation (UA/NSTEMI) patients. Data were collected from all over one year April 1, 2011. The included...

10.1016/j.ejccm.2014.07.001 article EN cc-by-nc-nd The Egyptian Journal of Critical Care Medicine 2014-04-01

Markers of platelet activity (P-selectin), fibrinolysis (d-dimer), thrombin (prothrombin fragments 1, 2 [PF1,2] and thrombin–antithrombin III complex [TAT]), inflammation (interleukin 1β [IL-1β]) were measured in 65 patients with mitral stenosis (MS) before weeks after percutaneous valvotomy (PMV) 23 controls. All markers significantly higher than the control decreased PMV. P-selectin change correlated changes left atrial diameter (LAD), pulmonary artery systolic pressure (PASP), IL-1β....

10.1177/1076029614533144 article EN Clinical and Applied Thrombosis/Hemostasis 2014-05-19

Background: The benefits of early abciximab administration and thrombus aspiration in ST elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PPCI) have previously been elaborated. However, whether there is an adjunctive effect among STEMI patients, with angiographic evidence thrombus, receiving prehospital remains unclear. Methods: In the context a fixed protocol for PPCI, 158 consecutive were enrolled, whom was started before hospital...

10.1111/j.1540-8183.2011.00686.x article EN Journal of Interventional Cardiology 2011-11-08

This study was performed to evaluate the feasibility and safety of early sheath removal after percutaneous coronary intervention (PCI) using a locally designed Assiut Femoral Compression Device (AFCD2) vs. manual compression (MC). Due antithrombotic therapy before, during, PCI, arterial femoral is generally not removed PCI. randomized, controlled trial. We enrolled all patients undergoing PCI at University Hospitals from September, 2013 December, 2013. At end hemostasis method randomly...

10.1016/j.ehj.2014.10.003 article EN cc-by-nc-nd The Egyptian Heart Journal 2014-10-30

After successful pulmonary vein isolation (PVI) for atrial fibrillation (AF), the left atrium (LA) undergoes reverse remodeling. However, few studies have directly studied (PV) remodeling and focused on whether pre PVI-PV conditions could predict outcome of procedure. We hypothesize that: (I) post PVI, in addition to LA PVs undergo a parallel degree remodeling; (II) that PV characteristics PVI can be used identify patients more likely sustain normal sinus rhythm (NSR).Patients (n=100)...

10.21037/cdt.2018.09.07 article EN Cardiovascular Diagnosis and Therapy 2019-01-28

Abstract Background Deferred stenting, despite being successful in early studies, showed no benefit recent trials. However, these trials were testing routine deferral; not patients with heavy thrombus burden. Results This is a prospective, Randomized Clinical Trial that included 150 who presented STEMI, allocated into three equal groups after the coronary angiography ± primary intervention and before stenting of culprit lesion; group (A) 50 deferral (B) late (C) immediate stenting. No-reflow...

10.1186/s43044-021-00203-3 article EN cc-by The Egyptian Heart Journal 2021-09-09
Coming Soon ...